Meta-analysis Finds Strong Placebo Response in Treatment of ADHD, Mid-range Among Nine Neurological Disorders

ADHD is a neurodevelopmental condition rooted in delayed or atypical maturation of the prefrontal cortex  (the brain region that governs self-regulation). This maturational lag underlies the hallmark difficulties with attention, hyperactivity, and impulsivity, and also impairs what researchers call executive function: the cognitive toolkit we rely on for working memory, impulse control, mental flexibility, emotional regulation, and the ability to tolerate delays in reward. 

The Background:

Standard treatments work through two main routes. Stimulant and non-stimulant medications are considered very safe and effective treatments, but are not without risk of side effects and are not appropriate for every ADHD patient. Behavioral and psychosocial interventions can improve self-regulation and social functioning, but they require sustained effort and produce variable results. These limitations have kept the search for better alternatives active. 

One candidate that has drawn growing attention is transcranial direct current stimulation (tDCS). The technique is appealingly simple: a weak electrical current is applied to the scalp through small electrodes, modulating the excitability of neurons in the underlying cortex without requiring surgery, anesthesia, or significant discomfort. Its safety profile and ease of use have made it attractive to researchers. 

The Study: 

A newly published meta-analysis set out to give the technique its most rigorous test yet, pooling results from randomized controlled trials, including crossover designs, that compared active tDCS against sham stimulation in people with ADHD across all age groups. 

The Results: 

The findings were consistently null. Across seven trials enrolling 303 participants, tDCS produced no significant reduction in overall ADHD symptom severity compared with sham. Breaking symptoms into their components made no difference: neither hyperactivity/impulsivity nor inattention improved. Turning to executive function, 18 studies with 872 participants found no meaningful gain in inhibitory control, and 12 studies with 506 participants found the same for working memory. Smaller bodies of evidence, including three studies on cognitive flexibility (122 participants) and two on hot executive function, the motivational and emotional dimension of self-regulation (86 participants),  similarly came up empty. Variation in outcomes across studies was small to moderate, and there was no evidence of publication bias skewing the picture. 

The authors’ conclusion was succinct: tDCS was well tolerated but “did not demonstrate significant overall efficacy for core ADHD symptoms or executive functions.” 

Disordered eating (a broad category of persistent, harmful patterns in eating or weight control) affects between 5% and 22% of children and adolescents worldwide, with similar rates seen in the United States. The consequences are far-reaching: these conditions are linked to bone fractures, anemia, malnutrition, dental erosion, obesity, diabetes, hypertension, and elevated cholesterol and triglycerides. They also carry one of the highest mortality rates of any psychiatric illness. 

Eating disorders rarely occur in isolation. They frequently arise alongside other psychiatric and neurological conditions. Yet, until now, no large-scale study had examined these co-occurrences in a nationally representative U.S. sample. A new study addresses that gap, focusing on children and adolescents aged 6–17 and the conditions most commonly associated with disordered eating, including ADHD. 

The Study: 

Researchers drew on data from the 2022–2023 National Survey of Children's Health (NSCH), a nationally representative, cross-sectional survey covering all 50 states and Washington, D.C. Households were selected using stratified, address-based sampling, and parents or guardians completed surveys about one randomly selected child per household. The final sample included 68,000 children and adolescents. 

Results: 

After accounting for factors including sex, age, race and ethnicity, household income, educational attainment, insurance status, and household language, children and adolescents with ADHD were 2.6 times more likely to have some form of disordered eating compared to their typically developing peers. 

The elevated risk appeared across a range of specific behaviors: 

• 60% more likely to over-exercise 

• Twice as likely to experience a fear of vomiting or choking 

• 2.4 times more likely to be extremely selective eaters, to skip meals, or to fast 

• 2.7 times more likely to purge food or vomit 

• 3 times more likely to show little interest in food 

• 3.2 times more likely to binge eat 

A greater tendency toward using diet pills, laxatives, or diuretics was also observed in the ADHD group, though this finding did not reach statistical significance. 

The Take-Away: 

These findings underscore a need to improve both prevention and treatment strategies for disordered eating, particularly in children and adolescents who have ADHD. Clinicians working with this population are advised to screen for a wide spectrum of disordered eating behaviors.

‍

‍

The Background:

For centuries, we’ve called the eyes the "windows to the soul," but for modern neurologists, they are quite literally a window into the brain. The retina and the central nervous system share the same embryonic origins, developing from the same neural tissue in the womb. Because of this deep biological connection, the back of your eye acts as a non-invasive map of your brain's health, displaying a complex web of nerves and blood vessels that can (theoretically!) mirror certain neurodevelopmental conditions. 

‍

Recently, a buzz rippled through the mental health community when a study published in partnership with Seoul National University Bundang Hospital claimed a massive breakthrough. Researchers developed an Artificial Intelligence (AI) model that could screen children for Attention-Deficit/Hyperactivity Disorder (ADHD) using nothing more than a simple retinal photograph. The study, which prospectively recruited children from Severance Hospital and Eunpyeong St. Mary’s Hospital, produced results that were staggering: the AI reportedly achieved an accuracy rate of  96.9%!

‍

In the world of medical testing, scientists use a metric called  AUROC  (Area Under the Receiver Operating Characteristic) to measure how well a test works.

• 0.5  means the test is no better than a coin flip (pure luck).
• 1.0  represents a perfect test with zero mistakes. 

‍

An AUROC of 96.9% is a near-perfect score, suggesting a tool is ready for immediate, real-world deployment. While headlines promised a revolution in mental health screening, a deeper look into this research and the study’s design has exposed that this 96.9% AUROC was more likely evidence of a flawed methodology rather than a biological reality.

‍

The Promise: How the AI "Sees" ADHD

To build their screening tool, researchers analyzed over 1,100 retinal images using a digital pipeline called AutoMorph and a machine-learning model known as XGBoost. The AI was trained to hunt for physical signals of the "Dopamine Connection." Dopamine is the primary neurotransmitter involved in ADHD, but it is also essential to the eye. It regulates synaptic formation, retinal blood flow, and vascular endothelial regulation. Because dopamine dysregulation influences how blood vessels grow and remodel, the study hypothesized that an ADHD brain would leave a unique "fingerprint" on the retinal vasculature, resulting in denser, thicker vessel structures.

On paper, the logic was sound: use AI to spot the subtle vascular remodeling caused by dopaminergic shifts. But a closer look at the investigation revealed that the AI wasn't just spotting ADHD; it was over-indexing on technical noise.

‍

Flaw #1: Batch Effects

The most significant "smoking gun" flagged by critics is a massive temporal mismatch. In other words, there was a severe disparity in the timeframes and conditions under which the retinal images for the two comparison groups were collected. For an AI to learn a biological condition, it must compare groups under identical technical conditions. Instead, this study created a time-traveling dataset:

• The ADHD Group:  323 children recruited prospectively in a tight 6-month window in  2022 .
• The Control Group:  323 children gathered retrospectively over a  17-year span  (2007 to 2024).This discrepancy triggers severe Batch Effects. This is a term scientists use to describe non-biological factors in an experiment that can cause inaccuracies in the data it produces. Fundus photography technology changed dramatically between 2007 and 2024. An investigation into the hardware uncovered shifts in camera models, lens optics, sensor degradation, and digital compression formats .Think of it this way: if you compare a selfie taken on the original 2007 iPhone with one from an iPhone 16, the AI doesn't need to look at your face to tell them apart; it just looks at the  2007 sensor noise  and pixel grain. The AI likely didn't learn to identify ADHD so much as it learned to distinguish between "old camera" and "new camera."

‍

Flaw #2: Control Group

A scientific study is only as reliable as its control group. The control in any experiment acts as a baseline against which the study group is compared. In this case, the control group should be composed of children without any neurodevelopmental disorders, or of “typically developing” children. 

In this study, the control group wasn't composed of healthy children from the community. Instead, they were patients visiting a tertiary ophthalmology clinic. Children visiting a specialist eye hospital are rarely "typical." They are there because they have symptomatic eye issues. This introduced a massive selection bias involving three major confounders:

• Refractive Errors (Myopia/Nearsightedness):  Severe myopia physically stretches the retina. This stretching alters vessel density and optic disc size, which were the exact markers the AI was examining.
• Strabismus:  Misaligned eyes.
• Ocular Anomalies:  Physical eye defects.Because these conditions directly alter retinal architecture, the AI likely learned to distinguish between "kids with ADHD" and "kids with severe eye problems," rather than "kids with ADHD" and "typical kids."

‍

Fatal Flaw #3: The "Mirror Image" Leakage

When training AI, you must never allow the "test questions" to leak into the "study material." The researchers, however, committed a fundamental violation of machine learning hygiene known as  Eye-to-Eye Data Leakage. The study split the data by the eye rather than by the participant. 

Human eyes are highly correlated; the left eye is a near-mirror of the right. If a child's left eye was used for training and their right eye was used for testing, the AI was effectively "cheating." Instead of learning the general traits of ADHD, the model was potentially memorizing individuals. This error artificially balloons accuracy metrics. 

‍

The True Test: Differential Diagnosis 

The true test of medical AI is diagnostic specificity, or differential diagnosis. This refers to the ability to tell one condition apart from another. While the model claimed 96.9% accuracy against a flawed control group, its performance collapsed when faced with real-world complexity.

When the researchers asked the AI to differentiate between ADHD and Autism Spectrum Disorder (ASD), the accuracy plummeted to a poor  63% AUROC. In real-world clinical settings, an accuracy of 63% is dangerously close to a 50% coin flip. Since ADHD frequently co-occurs with ASD, anxiety, or intellectual disabilities, an AI that cannot handle these "clinical differentials" is functionally useless in a doctor's office. The failure at this stage proves the model was likely detecting technical quirks of the dataset rather than a unique biological marker for ADHD.

‍

Conclusion:

To move from the lab to the clinic, we must establish a foundation built on rigor rather than high-speed data scraping. Moving forward, we must demand these 3 Pillars of Trusted Medical AI :

1. Prospective, Unified Hardware:  Data must be collected on identical camera systems with the same protocols to eliminate technical "batch effects."
2. Healthy, Community-Based Controls:  Comparisons must be made against truly "typically developing" children, not patients from eye clinics with their own retinal anomalies.
3. Rigorous External Validation:  AI models must be tested on independent datasets from entirely different hospital networks to ensure they aren't just "memorizing" one hospital's specific machinery.Artificial Intelligence holds immense potential, but we must demand detective-like scrutiny before these tools reach our children. In the search for the "window to the mind," we have to make sure we aren't just looking at a smudge on the glass.

‍

The dream of a quick eye scan to diagnose ADHD is not dead, but it must be rescued from "fast science" shortcuts and buzzy headlines. 

‍